Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-free Remission”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableUnknownNCT00449319
What this trial is testing

AML Treatment in Untreated Adult Patients

Who this might be right for
Leukemia, Myelocytic, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicableEnded earlyNCT02485353
What this trial is testing

Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML

Who this might be right for
Leukemia, Myeloid, Acute
Hamid Sayar 2
Not applicableUnknownNCT03062436
What this trial is testing

To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission

Who this might be right for
Chronic Myeloid LeukemiaTreatment Free Remission
Command Hospital, India 27
Testing effectiveness (Phase 2)Study completedNCT01784068
What this trial is testing

Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 215
Large-scale testing (Phase 3)Study completedNCT01456351
What this trial is testing

Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab

Who this might be right for
Non-Hodgkin's LymphomaMantle Cell Lymphoma
University of Giessen 230
Large-scale testing (Phase 3)UnknownNCT01134484
What this trial is testing

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Michele Cavo 480
Not applicableUnknownNCT05152537
What this trial is testing

FLOR3 Gene Polymorphism in Predicting Outcomes of Tyrosine Kinase Inhibitor（TKI）Stopping in Chronic Myeloid Leukemia

Who this might be right for
FolateCMLTreatment-free Remission
Affiliated Hospital of Nantong University 15
Testing effectiveness (Phase 2)Study completedNCT01744665
What this trial is testing

A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation

Who this might be right for
CML
Novartis Pharmaceuticals 59
Not applicableStudy completedNCT03736044
What this trial is testing

Reconstitution of CD4+CD25highCD127low/-Tcell

Who this might be right for
Rheumatoid Arthritis
University Hospital of Ferrara 48
Post-approval studies (Phase 4)UnknownNCT02602314
What this trial is testing

Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia

Who this might be right for
Chronyc Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 450
Testing effectiveness (Phase 2)Looking for participantsNCT06368414
What this trial is testing

Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia, Chronic Phase
Korean Society of Hematology 69
Testing effectiveness (Phase 2)Study completedNCT02852486
What this trial is testing

Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response

Who this might be right for
Leukemia, Chronic Myeloid
University of Campinas, Brazil 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT03610971
What this trial is testing

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

Who this might be right for
Chronic Phase Chronic Myeloid LeukemiaChronic Myeloid Leukemia, Chronic Phase
H. Lee Moffitt Cancer Center and Research Institute 24
Large-scale testing (Phase 3)Study completedNCT02980731
What this trial is testing

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
AbbVie 210
Not applicableUnknownNCT04422171
What this trial is testing

A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar

Who this might be right for
IBD Patients, Originator Treatment, Biosimilar, Switch Back
University Hospital, Grenoble 400
Not applicableUnknownNCT05926128
What this trial is testing

Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
CML
Fundaleu 75
Large-scale testing (Phase 3)Study completedNCT01743989
What this trial is testing

Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.

Who this might be right for
Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Novartis Pharmaceuticals 620
Large-scale testing (Phase 3)Study completedNCT00074542
What this trial is testing

An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Tillotts Pharma AG 364
Not applicableNot Yet RecruitingNCT05440747
What this trial is testing

Treatment Free Remission (TFR) in CML Patients （CML-CP）Study

Who this might be right for
Chronic Myeloid LeukemiaTreatment-free Remission
Guangdong Provincial People's Hospital 203
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191
What this trial is testing

Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

Who this might be right for
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Novartis Pharmaceuticals 568
Load More Results